Studies have shown an improvement of endothelial dysfunction by enhancing NOS-III expression in a rat model of pulmonary hypertension and in apolipoprotein E (ApoE)–deficient mice [38, 39]. Here, NOS3 is linked to pulmonary arterial hypertension.